FDA Approval For Behçet's Disease Drug Granted For This Company

FDA Grants Soligenix "Fast Track" Designation for Dusquetide: A Breakthrough in Behçet's Disease Treatment.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant development for patients suffering from Behçet's disease, the U.S. Food and Drug Administration (FDA) has granted "Fast Track" designation to Soligenix Inc.'s (NASDAQ: SNGX) drug candidate, Du…